Pharma Journalist - Page 38 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

FDA Expands RINVOQ Use for Ulcerative Colitis and Crohn’s Disease Patients

FDA Approves Once-Monthly UZEDY for Maintenance Treatment of Bipolar I Disorder

FDA Approves Celltrion’s EYDENZELT, a Biosimilar to EYLEA, for Multiple Retinal Diseases

Cidara’s CD388 Receives FDA Breakthrough Therapy Designation for Flu Prevention in High-Risk

FDA Approves Boehringer Ingelheim’s JASCAYD as First PDE4B Inhibitor for Idiopathic Pulmonary Fibrosis

Turbine and AstraZeneca Partner to Advance ADC Discovery with Virtual Models

LEAN Cell & Gene Summit Series Expands Following Successful Boston Debut Next event to take place in National Harbor, MD, November 6, 2025

Werewolf Therapeutics Receives FDA Fast Track Designation for WTX-124 in Advanced Melanoma

FDA Approves Regeneron’s Libtayo as First Adjuvant Immunotherapy for High-Risk CSCC

Arthrosi Therapeutics Secures $153 Million in Series E Financing to Advance Late-Stage Gout Treatment